TLR3-driven IFN-β antagonizes STAT5-activating cytokines and suppresses innate type 2 response in the lung - 03/03/22
Abstract |
Background |
Group 2 innate lymphoid cells (ILC2s) are involved in type 2 immune responses in mucosal organs and are associated with various allergic diseases in humans. Studies are needed to understand the molecules and pathways that control ILC2s.
Objective |
The aims of this study were to develop a mouse model that limits the innate type 2 immune response in the lung and to investigate the immunologic mechanisms involved in regulation of lung ILC2s.
Methods |
Naive BALB/c mice were administered various Toll-like receptor agonists and exposed intranasally to the fungal allergen Alternaria alternata. The mechanisms were investigated using gene knockout mice as well as cultures of lung cells and isolated lung ILC2s.
Results |
Polyinosinic–polycytidylic acid, or poly (I:C), effectively inhibited innate type 2 response to A alternata. Poly (I:C) promoted production of IFNα, -β, and -γ, and its inhibitory effects were dependent on the IFN-α/β receptor pathway. IFN-β was 100 times more potent than IFN-α at inhibiting type 2 cytokine production by lung ILC2s. Signal transducer and activator of transcription 5 (STAT5)-activating cytokines, including IL-2, IL-7, and thymic stromal lymphopoietin, but not IL-33, promoted survival and proliferation of lung ILC2s in vitro, while IFN-β blocked these effects. Expression of the transcription factor GATA3, which is critical for differentiation and maintenance of ILC2s, was inhibited by IFN-β.
Conclusions |
IFN-β blocks the effects of STAT5-activating cytokines on lung ILC2s and inhibits their survival and effector functions. Administration of IFN-β may provide a new strategy to treat diseases involving ILC2s.
Le texte complet de cet article est disponible en PDF.Graphical abstract |
Key words : Group 2 innate lymphoid cell, lung, poly (I:C), IL-5, IL-7, IL-13, IL-33, TSLP, IFN-β
Abbreviations used : 7-AAD, BAL, CFSE, ELISA, FACS, GATA3, IFNAR, IFNGR, Il5Venus, ILC2, Lin−, MFI, mRNA, PBS, poly (I:C), RORα, STAT5, TLR, TSLP, WT
Plan
| This work was supported by grants from the National Institutes of Health (R37AI71106, R0HL117823), Mayo Graduate School, and Mayo Foundation. |
|
| Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
Vol 149 - N° 3
P. 1044 - mars 2022 Retour au numéro
Article précédent
- IgE recognition of the house dust mite allergen Der p 37 is associated with asthma
- Huey-Jy Huang, Yvonne Resch-Marat, Anne Casset, Margit Weghofer, Petra Zieglmayer, René Zieglmayer, Patrick Lemell, Friedrich Horak, Kuan-Wei Chen, Ekaterina Potapova, Paolo M. Matricardi, Gabrielle Pauli, Monika Grote, Rudolf Valenta, Susanne Vrtala
- A novel approach for studying mast cell–driven disorders: Mast cells derived from induced pluripotent stem cells
- Yanyan Luo, Valeria Fernandez Vallone, Jiajun He, Stefan Frischbutter, Pavel Kolkhir, Sherezade Moñino-Romero, Harald Stachelscheid, Viktoria Streu-Haddad, Marcus Maurer, Frank Siebenhaar, Jörg Scheffel
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?